Added 2 days ago Drug news

FDA accepts NDA for iclaprim to treat ABSSSI.- Motif Bio plc.

Motif Bio plc has announced that the FDA has accepted for filing the New Drug Application (NDA) for iclaprim, a...

Added 2 days ago Drug news

Advisory Committee recommends ALIS to treat nontuberculous mycobacterial (NTM) lung disease caused by Mycobacterium avium complex . Insmed Inc.

Insmed Incorporated has announced that the FDA Antimicrobial Drugs Advisory Committee voted 12 to 2 in favor of the safety...

Added 4 days ago Drug news

Advisory Committee positive for omadacycline for ABSSSI and CABP.- Paratek Pharmaceuticals,

Paratek Pharmaceuticals, Inc.has announced that the Antimicrobials Drug Advisory Committee of the FDA voted in favor of the approval of...

Guidelines on Urological Infections

The European Association of Urology (EAU) Urological Infections Guidelines Panel has compiled these clinical guidelines to provide medical professionals with evidence-based information and recommendations for...

Added 2 years ago

The Prevention of Early-onset Neonatal Group B Streptococcal Disease

The purpose of this guideline is to provide guidance for obstetricians, midwives and neonatologists on the prevention of early-onset (less than 7 days of age) neonatal group B streptococcal (EOGBS) disease...

Added 6 years ago

Fever in under 5s: assessment and initial management

This guideline covers the assessment and early management of fever with no obvious cause in children aged under 5.

Added 5 years ago

Pseudomonas aeruginosa in cystic fibrosis patients with c.1652G›A (G551D)-CFTR treated with ivacaftor-Changes in microbiological parameters.

The CFTR potentiator, ivacaftor (IVA), has been widely used in the treatment of cystic fibrosis (CF) patients with the G551D mutation. To date, there has been limited information on the microbiological status...

Added 6 months ago

Early goal-directed therapy in the treatment of severe sepsis and septic shock.

Goal-directed therapy has been used for severe sepsis and septic shock in the intensive care unit.

Added 1 year ago

Early, goal-directed therapy for septic shock – a patient-level meta-analysis.

After a single-center trial and observational studies suggesting that early, goal-directed therapy (EGDT) reduced mortality from septicshock, three multicenter trials (ProCESS, ARISE, and ProMISe) showed no benefit.

Added 1 year ago